The global sleep apnea devices market, valued at USD 6.47 billion in 2024, stood at USD 6.93 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2032, culminating in a forecasted valuation of USD 11.61 billion by the end of the period.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719
The growth in this market is expected to be driven by a large pool of undiagnosed sleep apnea patients globally, as well as favorable reimbursement and financial aid for sleep apnea devices and therapies. However, the high prices of CPAP machines and limited insurance access in emerging economies, complex referral pathways, long waiting periods, delayed diagnosis, and the availability of alternative therapies and medications may hinder the growth of this market.
- By product type, the therapeutic devices segment accounted for the largest share in 2024.
- By age group, the age 40-60 years segment is projected to register the highest CAGR of 11.8% during the forecast period.
- By gender type, the male gender segment is projected to witness the highest growth rate during the forecast period.
- By end user, the home care settings segment is projected to register the highest CAGR of 11.8% during the forecast period.
- Asia Pacific is the fastest-growing region in the global sleep apnea devices market, registering a CAGR of 11.8% during the forecast period.
- ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare Limited (New Zealand) are identified as some of the star players in the sleep apnea devices market, given their strong market share and product footprint.
- BRAEBON Medical Corporation (Canada) and Apnea Sciences (US) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The sleep apnea devices market is growing steadily due to the growing awareness about the effects of untreated sleep apnea among patients, increasing usage of oral appliances among patients with mild-to-moderate sleep apnea, and the rising number of companies in the sleep apnea devices and oral appliances market.
